MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
ARCH Venture Partners - (#8 Healthcare Investor 2013) WBT
Finance & Acquisitions: Arch Ventures
*Portfolio Companies: Arch Ventures
Chiasma Corp (NASDAQ:CHMA)
Organization & Developments: Chiasma
Parents
Chiasma Corp (NASDAQ:CHMA)
Children
2020: Revisiting Chiasma
2021: Chiasma: Undervalued Despite Approval And Market Potential Of MYCAPSSA
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide.
Proprietary platform for bulk delivery of therapeutics into the bloodstream via nano-particles
Jumps
*Key People: Chiasma
Finance & Acquisition: Chiasma